• ADVAIR DISKUS is contraindicated for primary treatment of status asthmaticus or other acute episodes of asthma or chronic obstructive pulmonary disease (COPD) where intensive measures are required.
• ADVAIR DISKUS is contraindicated in patients with severe hypersensitivity to milk proteins

...continue reading

The breath-actuated DISKUS® device requires no hand-breath coordination

Consistent Drug Delivery Even in Patients With Very Severe Airflow Limitation

  • Patients with very severe airflow limitation (FEV1 20% to 30% of predicted) can achieve an airflow rate sufficient to receive an effective dose
  • 1 inhalation twice daily
  • Built-in dose counter—60 doses (30-day supply)

Indications for ADVAIR DISKUS 250/50 for COPD

  • ADVAIR DISKUS 250/50 is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. ADVAIR DISKUS 250/50 is also indicated to reduce exacerbations of COPD in patients with a history of exacerbations.
  • ADVAIR DISKUS 250/50 twice daily is the only approved dosage for the treatment of COPD because an efficacy advantage of the higher strength ADVAIR DISKUS 500/50 over ADVAIR DISKUS 250/50 has not been demonstrated.
  • ADVAIR DISKUS is NOT indicated for the relief of acute bronchospasm.

830422R0 March 2018